Related Experiment Videos
[Alzheimer's disease and the immune system response]
1Tokyo Institute of Psychiatry.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 1, 1994
Summary
Alzheimer's disease (AD) involves chronic inflammation where microglia fail to clear brain debris. This persistent immune response may drive neuronal damage, suggesting anti-inflammatory treatments could be beneficial.
Area of Science:
- Neuroimmunology
- Pathology of Alzheimer's disease
Context:
- Alzheimer's disease (AD) brain tissue exhibits elements of the innate immune system.
- Senile plaques and neurofibrillary tangles are sites of chronic inflammation involving microglia, the brain's resident macrophages.
- Complement, coagulation, and fibrinolysis systems are activated in AD lesions.
Purpose:
- To investigate the role of the innate immune system, particularly microglia, in Alzheimer's disease pathogenesis.
- To understand the implications of microglial dysfunction in the accumulation of pathological hallmarks in AD.
Summary:
- Immunohistochemical analysis reveals innate immune components in the brains of AD patients.
- Microglia are central to the inflammatory response at plaque and tangle sites but fail to phagocytose pathological debris.
- This microglial "frustration" may perpetuate inflammation and lead to neurodegeneration.
Impact:
- Findings suggest that persistent, ineffective microglial responses contribute to neuronal damage in AD.
- The lower incidence of AD in rheumatoid arthritis patients on anti-inflammatory medication supports the role of inflammation in AD.
- Highlights potential therapeutic targets within neuroinflammatory pathways for AD treatment.